Notice2024-08447
Solicitation of Nominations for Appointment to the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 22, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is seeking nominations for membership on the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC). CHAC consists of 18 experts in fields associated with public health; epidemiology; laboratory practice; immunology; infectious diseases; substance use disorder; behavioral science; health education; healthcare delivery; state health programs; clinical care; preventive health; medical education; health services and clinical research; health equity; and healthcare financing, who are selected by the Secretary, HHS.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 78 (Monday, April 22, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 78 (Monday, April 22, 2024)]
[Notices]
[Pages 29335-29336]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-08447]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the CDC/HRSA
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and
Treatment
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), within the Department
of Health and Human Services (HHS), is seeking nominations for
membership on the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis
and STD Prevention and Treatment (CHAC). CHAC consists of 18 experts in
fields associated with public health; epidemiology; laboratory
practice; immunology; infectious diseases; substance use disorder;
behavioral science; health education; healthcare delivery; state health
programs; clinical care; preventive health; medical education; health
services and clinical research; health equity; and healthcare
financing, who are selected by the Secretary, HHS.
DATES: Nominations for membership on CHAC must be received no later
than October 1, 2024. Packages received after
[[Page 29336]]
this time will not be considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to <a href="/cdn-cgi/l/email-protection#85ebe6ededf6f1f5f5eae9ece6fcc5e6e1e6abe2eaf3"><span class="__cf_email__" data-cfemail="3759545f5f44434747585b5e544e7754535419505841">[email protected]</span></a>
with the subject line ``CHAC 2025 Nomination.''
FOR FURTHER INFORMATION CONTACT: Marah Condit, M.S., Committee
Management Lead, Office of Policy, Planning, and Partnerships, National
Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6,
Atlanta, Georgia 30329-4027. Telephone: (404) 639-3423; Email:
<a href="/cdn-cgi/l/email-protection#9ff1fcf7f7ecebefeff0f3f6fce6dffcfbfcb1f8f0e9"><span class="__cf_email__" data-cfemail="b4dad7dcdcc7c0c4c4dbd8ddd7cdf4d7d0d79ad3dbc2">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Secretary, Department of Health and
Human Services (HHS), and by delegation, the Director, Centers for
Disease Control and Prevention (CDC), and the Administrator, Health
Resources and Services Administration (HRSA), are authorized by the
Public Health Service Act to: (1) conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases and other impairments; (2) assist states and their
political subdivisions in preventing, suppressing, and treating
communicable diseases and other preventable conditions and in promoting
health and well-being; (3) assist public and non-profit private
entities in preventing, controlling and treating sexually transmitted
diseases (STDs), including the human immunodeficiency virus (HIV); (4)
improve health and achieve health equity through access to quality
services and a skilled health workforce and innovative programs; (5)
support healthcare services to persons with or who experience risk for
HIV, viral hepatitis, and other STDs; (6) advance the education of
health professionals and the public about HIV, viral hepatitis, and
other STDs; and (7) improve adolescent and school health as it pertains
to HIV, viral hepatitis, and STDs.
The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment (CHAC) meets at least two times each calendar
year, or at the discretion of the Designated Federal Officers in
consultation with the CHAC co-chairs.
HHS policy stipulates that committee membership be balanced in
terms of points of view represented and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Current participation on Federal workgroups or prior
experience serving on a Federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships. The
CHAC charter stipulates that the Committee must include at least four
members who are persons with HIV. The Committee may also include
representation from persons with lived experience, such as those who
have experienced viral hepatitis, STDs, and drug use; state and local
health and education agencies; HIV/viral hepatitis/STD community-based
organizations; and the ethics or faith-based community.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning of and annually
during their terms. Individuals who are selected for appointment will
be required to provide detailed information regarding their financial
interests and, for example, any work they do for the federal government
through research grants or contracts. Disclosure of this information is
required in order for CDC ethics officials to determine whether there
is a conflict between the SGE's public duties as a member of CHAC and
the SGE's private interests, including an appearance of a loss of
impartiality as defined by Federal laws and regulations, and to
identify any required remedial action needed to address the potential
conflict.
CDC and HRSA review potential candidates for CHAC membership when a
vacancy arises and provide a slate of nominees for consideration to the
Secretary of HHS for final selection. CDC and HRSA each publish a
Federal Register notice and will be using a joint process to nominate
nominees on a rolling basis; thus, applications received by CDC will be
shared with HRSA for consideration. Therefore, potential candidates
need only apply in response to one of the Federal Register notices. HHS
notifies selected candidates of their appointment near the start of the
term in December 2025, or as soon as the HHS selection process is
completed. Note that the need for different expertise varies from year
to year and a candidate who is not selected in one year may be
reconsidered in a subsequent year.
Candidates should submit the following items:
[ssquf] A letter of interest or personal statement from the nominee
stating how the nominee's expertise would inform the work of CHAC
[ssquf] A biographical sketch of the nominee (500 words or fewer)
[ssquf] Current curriculum vitae or resume, including complete
contact information (telephone numbers, mailing address, and email
address)
[ssquf] At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (e.g., CDC, National Institutes of
Health, Food and Drug Administration).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate. CDC and HRSA will collect and
retain nominations received for up to two years to create a pool of
potential CHAC nominees. When a vacancy occurs, CDC and HRSA will
review nominations and may contact nominees at that time.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-08447 Filed 4-19-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 22, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.